Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection.

Source:http://linkedlifedata.com/resource/pubmed/id/11266971

Download in:

View as

General Info

PMID
11266971